{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:27:58Z","timestamp":1772749678142,"version":"3.50.1"},"reference-count":200,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jare.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T06:01:31Z","timestamp":1340431291000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Novel Therapeutic and Prevention Approaches for Schistosomiasis: Review"],"prefix":"10.1016","volume":"4","author":[{"given":"Rashika A.F.","family":"El Ridi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem A.-M.","family":"Tallima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2012.05.002_b0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.jare.2012.05.002_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(10)70099-2","article-title":"Schistosomiasis elimination: lessons from the past guide the future","volume":"10","author":"Gray","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0020","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/hv.7.11.17017","article-title":"Schistosomiasis vaccines","volume":"7","author":"Siddiqui","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jare.2012.05.002_b0025","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1017\/S0031182009991600","article-title":"Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution","volume":"136","author":"Utzinger","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0030","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1371\/journal.pntd.0000539","article-title":"The neglected tropical diseases and their devastating health and economic impact on the member nations of the organisation of the Islamic conference","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0035","doi-asserted-by":"crossref","unstructured":"Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases of the middle east and north Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 201;6:e1475.","DOI":"10.1371\/journal.pntd.0001475"},{"key":"10.1016\/j.jare.2012.05.002_b0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1471-4922(02)00019-3","article-title":"Invasion of skin by schistosome cercariae: some neglected facts","volume":"19","author":"Curwen","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pt.2005.03.003","article-title":"Comparison of skin invasion among three major species of Schistosoma","volume":"21","author":"He","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s004360050407","article-title":"Schistosoma haematobium, S. intercalatum, S. japonicum, S. mansoni, S. rodhaini in mice: relationship between patterns of lung migration by schistosomula and perfusion recovery of adult worms","volume":"84","author":"Rheinberg","year":"1998","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jare.2012.05.002_b0055","unstructured":"Sturrock RF. The parasites and their life cycle. In: Jordan P, Webbe G, Sturrock RF, editors. Human schistosomiasis. Wallingford (UK): CAB International; 1993. p. 1\u201332."},{"key":"10.1016\/j.jare.2012.05.002_b0060","unstructured":"Farid Z. Schistosomes with terminal-spined eggs: pathological and clinical aspects. In: Jordan P, Webbe G, Sturrock RF, editors. Human schistosomiasis. Wallingford (UK): CAB International; 1993. p. 159\u201393."},{"key":"10.1016\/j.jare.2012.05.002_b0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11938-007-0050-y","article-title":"Hepatic schistosomiasis","volume":"10","author":"Andersson","year":"2007","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.jare.2012.05.002_b0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-3024.2009.01098.x","article-title":"Immunopatho-genesis of human schistosomiasis","volume":"3","author":"Burke","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0075","doi-asserted-by":"crossref","first-page":"e1396","DOI":"10.1371\/journal.pntd.0001396","article-title":"Examining the relationship between urogenital schistosomiasis and HIV infection","volume":"5","author":"Mbabazi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/COH.0b013e328351b9e3","article-title":"The effects of schistosomiasis on HIV\/AIDS infection, progression and transmission","volume":"7","author":"Secor","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jare.2012.05.002_b0085","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21173","article-title":"Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors","volume":"43","author":"Strickland","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2012.05.002_b0090","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.3748\/wjg.15.4993","article-title":"Comorbidities affecting the course and response to therapy","volume":"15","author":"El-Zayadi","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jare.2012.05.002_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-391429-3.00005-8","article-title":"Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths","volume":"77","author":"Abruzzi","year":"2011","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0006-2952(66)90285-1","article-title":"Factors affecting the inhibition of phosphofructokinase activity of Schistosoma mansoni by trivalent organic antimonials","volume":"115","author":"Bueding","year":"1966","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2012.05.002_b0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0035-9203(71)90070-8","article-title":"The effect of metrifonate in vitro on Schistosoma haematobium and Schistosoma mansoni adults","volume":"65","author":"Denham","year":"1971","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00351766","article-title":"Metrifonate. Summary of toxicological and pharmacological information available","volume":"41","author":"Holmstedt","year":"1978","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jare.2012.05.002_b0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(65)90338-7","article-title":"Treatment of urinary schistosomiasis: practice and theory","volume":"2","author":"Forsyth","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2012.05.002_b0120","series-title":"Schistosomiasis","first-page":"413","article-title":"Strategies for control of infection and disease: current practice and future potential","author":"Bergquist","year":"2001"},{"key":"10.1016\/j.jare.2012.05.002_b0125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0035-9203(73)90039-4","article-title":"Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates","volume":"67","author":"Foster","year":"1973","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0035-9203(87)90282-3","article-title":"A review of clinical experience with oxamniquine","volume":"81","author":"Foster","year":"1987","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4269\/ajtmh.1985.34.112","article-title":"Studies on the mode of action of oxamniquine and related schistosomicidal drugs","volume":"34","author":"Pica-Mattoccia","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","article-title":"Antischistosomal drugs: past, present \u2026 and future?","volume":"68","author":"Cioli","year":"1995","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.jare.2012.05.002_b0145","unstructured":"Davis A. Antischistosomal drugs and clinical practice. In: Jordan P, Webbe G, Sturrock RF, editors. Human schistosomiasis. Wallingford: CAB International; 1993. p. 367\u2013404."},{"key":"10.1016\/j.jare.2012.05.002_b0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0924-8579(94)90032-9","article-title":"Use of praziquantel against schistosomiasis: a review of current status","volume":"4","author":"Kumar","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jare.2012.05.002_b0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/151.6.1130","article-title":"Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo","volume":"151","author":"Xiao","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0160","first-page":"544","article-title":"In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study","volume":"31","author":"Mehlhorn","year":"1981","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"10.1016\/j.jare.2012.05.002_b0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0163-7258(85)90020-8","article-title":"Praziquantel: mechanisms of anti-schistosomal activity","volume":"29","author":"Andrews","year":"1985","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.jare.2012.05.002_b0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0169-4758(92)90070-I","article-title":"Praziquantel: the enigmatic antiparasitic","volume":"8","author":"Day","year":"1992","journal-title":"Parasitol Today"},{"key":"10.1016\/j.jare.2012.05.002_b0175","doi-asserted-by":"crossref","first-page":"36873","DOI":"10.1074\/jbc.C100273200","article-title":"Schistosome calcium channel \u03b2 subunits unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel","volume":"276","author":"Kohn","year":"2001","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.jare.2012.05.002_b0180","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1017\/S0031182005008346","article-title":"Ca2+ signalling, voltage-gated Ca2+ channels and praziquantel in flatworm neuromusculature","volume":"131","author":"Greenberg","year":"2005","journal-title":"Parasitology"},{"issue":"36","key":"10.1016\/j.jare.2012.05.002_b0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijpara.2006.02.002","article-title":"Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action","volume":"31","author":"Jeziorski","year":"2006","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/wmts.19","article-title":"Calcium channels of schistosomes: unresolved questions and unexpected answers","volume":"1","author":"Salvador-Recatal\u00e0","year":"2012","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"10.1016\/j.jare.2012.05.002_b0195","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0166-6851(88)90119-3","article-title":"Influence of praziquantel and Ca2+ on the bilayer-isotropic-hexagonal transition of model membranes","volume":"29","author":"Harder","year":"1988","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0205","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0006-2952(88)90026-3","article-title":"Mode of insertion of praziquantel and derivatives into lipid membranes","volume":"37","author":"Schepers","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2012.05.002_b0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0031182000080720","article-title":"Altered behaviour of carbohydrate-bound molecules and lipids in areas of the tegument of adult Schistosoma mansoni worms damaged by praziquantel","volume":"100","author":"Lima","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","article-title":"Drugs for the control of parasitic diseases: current status and development in schistosomiasis","volume":"19","author":"Fenwick","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0220","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1017\/S0031182009000493","article-title":"Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs","volume":"136","author":"Doenhoff","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0225","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1017\/S0031182011001235","article-title":"Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children","volume":"138","author":"Stothard","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0230","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.trstmh.2011.07.013","article-title":"Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole community","volume":"105","author":"Oshish","year":"2011","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0235","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1371\/journal.pntd.0001326","article-title":"Schistosomiais and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration","volume":"5","author":"Leslie","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0240","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1046\/j.1365-3156.2001.00811.x","article-title":"Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence","volume":"6","author":"Gryseels","year":"2001","journal-title":"Trop Med Intl Hlth"},{"key":"10.1016\/j.jare.2012.05.002_b0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0035-9203(03)00003-8","article-title":"Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d\u2019Ivoire","volume":"98","author":"Raso","year":"2004","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0250","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S003118201000154X","article-title":"Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt","volume":"138","author":"Barakat","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0255","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0169-4758(96)10029-6","article-title":"Schistosome resistance to praziquantel: fact or artifact?","volume":"12","author":"Fallon","year":"1996","journal-title":"Parasitol Today"},{"key":"10.1016\/j.jare.2012.05.002_b0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/expr.1997.4229","article-title":"The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel","volume":"87","author":"Bennett","year":"1997","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0169-4758(99)01510-0","article-title":"Praziquantel \u2013 its use, cost and possible development of resistance","volume":"15","author":"Kusel","year":"1999","journal-title":"Parasitol Today"},{"key":"10.1016\/j.jare.2012.05.002_b0270","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","article-title":"Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers","volume":"60","author":"Ismail","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0275","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1645\/GE-1297.1","article-title":"Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure","volume":"94","author":"Sabra","year":"2008","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0031182000073704","article-title":"Schistosoma mansoni: praziquantel-induced tegumental lesion exposes actin of surface spines and allows binding of actin depolymerizing factor, gelsolin","volume":"105","author":"Linder","year":"1992","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0285","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijantimicag.2006.12.018","article-title":"Praziquantel binds Schistosoma mansoni adult worm actin","volume":"29","author":"Tallima","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jare.2012.05.002_b0290","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ijantimicag.2007.08.002","article-title":"Re: is actin the praziquantel receptor?","volume":"30","author":"Tallima","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jare.2012.05.002_b0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exppara.2006.09.017","article-title":"Cytochalasin D abolishes the schistosomicidal activity of praziquantel","volume":"115","author":"Pica-Mattoccia","year":"2007","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0300","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/AAC.01222-08","article-title":"Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni","volume":"53","author":"Gnanasekar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0305","first-page":"491","article-title":"Antiparasitic treatments in pregnant women and in children in 2003","volume":"63","author":"Richard-Lenoble","year":"2003","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.jare.2012.05.002_b0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1747-0285.2011.01288.x","article-title":"MCR synthesis of praziquantel derivatives","volume":"79","author":"Liu","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.jare.2012.05.002_b1005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1747-0285.2012.01354.x","article-title":"Synthesis, biological evaluation and structure-activity relationship of clonazepam, meclonazepam and 1,4-benzodiazepine compounds with schistosomicidal activity","volume":"79","author":"Menezes","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.jare.2012.05.002_b0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.68.24","article-title":"Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections","volume":"68","author":"N\u2019Goran","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0001-706X(01)00138-3","article-title":"Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals","volume":"80","author":"Utzinger","year":"2001","journal-title":"Acta Trop"},{"key":"10.1016\/j.jare.2012.05.002_b0330","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.47.5.1487-1495.2003","article-title":"Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials","volume":"47","author":"Utzinger","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1645\/GE-322R","article-title":"Artemether as adjuvant therapy to praziquantel in murine Egyptian Schistosomiasis mansoni","volume":"91","author":"Mahmoud","year":"2005","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0340","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1600-0463.2010.02645.x","article-title":"Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment","volume":"118","author":"Botros","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.jare.2012.05.002_b1010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-3305-5-9","article-title":"Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis","volume":"5","author":"El-Lakkany","year":"2012","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.jare.2012.05.002_b0350","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S0031182011002241","article-title":"The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice","volume":"139","author":"Chen","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0355","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0001-706X(02)00009-8","article-title":"Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia","volume":"82","author":"Xiao","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.jare.2012.05.002_b0360","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/AAC.33.9.1557","article-title":"In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni","volume":"33","author":"Xiao","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0365","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0020-7519(00)00091-6","article-title":"Effect of artemether against Schistosoma haematobium in experimentally infected hamsters","volume":"30","author":"Xiao","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0370","first-page":"105","article-title":"Artemisinins for schistosomiasis and beyond","volume":"8","author":"Utzinger","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jare.2012.05.002_b0375","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00436-010-2163-9","article-title":"Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection","volume":"108","author":"Abdul-Ghani","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jare.2012.05.002_b0380","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1371\/journal.pntd.0000350","article-title":"Mefloquine \u2013 an aminoalcohol with promising antischistosomal properties in mice","volume":"3","author":"Keiser","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4269\/ajtmh.2010.09-0461","article-title":"Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice","volume":"82","author":"Keiser","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0390","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species","volume":"51","author":"Xiao","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0395","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/AAC.47.12.3853-3858.2003","article-title":"Activity of 9-(S)-[3-hydroxy-2- (phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice","volume":"47","author":"Botros","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0400","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1128\/AAC.00840-09","article-title":"Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl] adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro","volume":"53","author":"Botros","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0405","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm1737","article-title":"Identification of oxadiazoles as new drug leads for the control of schistosomiasis","volume":"14","author":"Sayed","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2012.05.002_b0410","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbagen.2011.06.024","article-title":"Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases","volume":"1810","author":"Prast-Nielsen","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.jare.2012.05.002_b0415","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pntd.0001474","article-title":"Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni","volume":"6","author":"Portela","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exppara.2011.01.021","article-title":"Antischistosomal action of thioxo-imidazolidine compounds: an ultrastructural and cytotoxicity study","volume":"128","author":"Neves","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0425","doi-asserted-by":"crossref","unstructured":"Pierce RJ, Dubois-Abdesselem F, Caby S, Trolet J, Lancelot J, Oger F, et al. Chromatin regulation in schistosomes and histone modifying enzymes as drug targets. Mem Inst Oswaldo Cruz 201;106:794\u2013801.","DOI":"10.1590\/S0074-02762011000700003"},{"key":"10.1016\/j.jare.2012.05.002_b0430","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.exppara.2010.08.021","article-title":"Schistosoma mansoni: in vitro schistosomicidal activity of piplartine","volume":"127","author":"Moraes","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0435","doi-asserted-by":"crossref","unstructured":"de Melo NI, Magalhaes LG, de Carvalho CE, Wakabayashi KA, de P Aguiar G, Ramos RC, et al. Schistosomicidal activity of the essential oil of Ageratum conyzoides L. (Asteraceae) against adult Schistosoma mansoni worms. Molecules 2011;16:762\u201373.","DOI":"10.3390\/molecules16010762"},{"key":"10.1016\/j.jare.2012.05.002_b0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-308X(01)50032-9","article-title":"Antiparasitic properties of medicinal plants and other naturally-occurring products","volume":"50","author":"Tagboto","year":"2001","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0445","doi-asserted-by":"crossref","unstructured":"Yousif F, Hifnawy MS, Soliman G, Boulos L, Labib T, Mahmoud S, et al. Large-scale in vitro screening of Egyptian native and cultivated plants for schistosomicidal activity. Pharmaceut Biol 2007;45:501\u201310.","DOI":"10.1080\/13880200701389425"},{"key":"10.1016\/j.jare.2012.05.002_b0450","unstructured":"Allegretti SM, Nascimento C, de Oliveira F, de Oliveira RN, Frezza TF, Garcia Rehder VL. The use of Brazilian medicinal plants to combat Schistosoma mansoni. In: Rokni MB, editor. Schistosomiasis. InTechOpen; 2012. p. 27\u201370. <http:\/\/www.intechopen.com\/books\/schistosomiasis\/the-use-of-brazilian-medicinal-plants-to-combat-schistosoma-mansoni> [chapter 3]."},{"key":"10.1016\/j.jare.2012.05.002_b0455","doi-asserted-by":"crossref","unstructured":"De Moraes J. Antischistosomal natural compounds: present challenges for new drug screens. In: Rodriguez-Morales A, editor. Current topics in tropical medicine. InTech Open; 2012. p. 323\u201357. <http:\/\/www.intechopen.com\/books\/current-topics-in-tropical-medicine\/antischistosomal-natural-compounds-present-challenges-for-new-drug-screens> [chapter 20].","DOI":"10.5772\/27740"},{"key":"10.1016\/j.jare.2012.05.002_b0460","first-page":"791","article-title":"Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice","volume":"45","author":"El-Ansary","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.jare.2012.05.002_b0465","first-page":"877","article-title":"Effect of curcuma longa or parziquantel on Schistosoma mansoni infected mice liver-histological and histochemical study","volume":"45","author":"El-Banhawey","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.jare.2012.05.002_b0470","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00436-008-1311-y","article-title":"In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms","volume":"104","author":"Magalh\u00e3es","year":"2009","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jare.2012.05.002_b0475","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.imbio.2008.11.017","article-title":"Immunomodulatory effects of curcumin treatment on murine Schistosomiasis mansoni","volume":"214","author":"Allam","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.jare.2012.05.002_b0480","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00436-011-2527-9","article-title":"Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity","volume":"110","author":"Luz","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jare.2012.05.002_b0485","first-page":"763","article-title":"An update review on Commiphora molmol and related species","volume":"38","author":"Tonkal","year":"2008","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1076\/phbi.39.2.127.6253","article-title":"Mirazid: a new schistosomicidal drug","volume":"39","author":"Badria","year":"2001","journal-title":"Pharma Biol"},{"key":"10.1016\/j.jare.2012.05.002_b0495","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4269\/ajtmh.2004.71.206","article-title":"Lack of evidence for an antischistosomal activity of myrrh in experimental animals","volume":"71","author":"Botros","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0500","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2005.72.119","article-title":"Efficacy of Mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households","volume":"72","author":"Botros","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0505","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4269\/ajtmh.2005.73.365","article-title":"Efficacy of myrrh in the treatment of human Schistosomiasis mansoni","volume":"73","author":"Barakat","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0510","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1590\/S0004-28032010000400014","article-title":"A short review of the anthelmintic role of Mirazid","volume":"47","author":"Yakoot","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jare.2012.05.002_b0515","doi-asserted-by":"crossref","first-page":"932","DOI":"10.26719\/2010.16.9.932","article-title":"Ineffectiveness of myrrh- derivative Mirazid against schistosomiasis and fascioliasis in humans","volume":"16","author":"Osman","year":"2010","journal-title":"Eastern Med Health J"},{"key":"10.1016\/j.jare.2012.05.002_b0520","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0065-308X(08)60188-8","article-title":"Ultrastructure of the tegument of Schistosoma","volume":"11","author":"Hockley","year":"1973","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0525","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.175.4023.720","article-title":"The fluid mosaic model of the structure of cell membranes","volume":"175","author":"Singer","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.jare.2012.05.002_b0530","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1645\/GE-3122RN","article-title":"Incubation of Schistosoma mansoni lung-stage schistosomula in corn oil exposes their surface membrane antigenic specificities","volume":"89","author":"El Ridi","year":"2003","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0535","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1645\/GE-3334","article-title":"Depletion of Schistosoma mansoni lung-stage schistosomula cholesterol by methyl-\u03b2-cyclodextrin dramatically increases specific antibody binding to surface membrane antigens","volume":"90","author":"El Ridi","year":"2004","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0540","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1645\/GE-439R","article-title":"Methyl-\u03b2-cyclodextrin treatment and filipin staining reveal therole of cholesterol in surface membrane antigen sequestration of Schistosoma mansoni and S. haematobium lung-stage larvae","volume":"91","author":"Tallima","year":"2005","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0545","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1645\/GE-514R.1","article-title":"In vitro and in vivo effects of unsaturated fatty acids on Schistosoma mansoni and S. haematobium lung-stage larvae","volume":"91","author":"Tallima","year":"2005","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0550","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1645\/GE-745R1.1","article-title":"Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface","volume":"92","author":"El Ridi","year":"2006","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0555","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1388-1981(00)00042-1","article-title":"Review. Physiology and pathophysiology of sphingolipid metabolism and signaling","volume":"1485","author":"Huwiler","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jare.2012.05.002_b0560","doi-asserted-by":"crossref","first-page":"41128","DOI":"10.1074\/jbc.M206747200","article-title":"Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase","volume":"277","author":"Luberto","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2012.05.002_b0565","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.97.11.5895","article-title":"Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jare.2012.05.002_b0570","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2567.1997.d01-2227.x","article-title":"Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids","volume":"91","author":"Robinson","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jare.2012.05.002_b0575","unstructured":"Tallima, H. Biochemical exposure of schistosoma surface membrane antigens. Ph.D thesis. Egypt: Faculty of Science, Cairo University; 2006."},{"key":"10.1016\/j.jare.2012.05.002_b0580","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2011.04.003","article-title":"Enzymatic activity and immunolocalization of Schistosoma mansoni and Schistosoma haematobium neutral sphingomyelinase","volume":"178","author":"Tallima","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0585","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S0031182007003174","article-title":"Evaluation of cholesterol content and impact on antigen exposure in the outer lipid bilayer of adult schistosomes","volume":"134","author":"Tallima","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0590","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2012.05.002_b0595","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0022-2275(20)32206-9","article-title":"Sources of eicosanoid precursor fatty acid pools in tissues","volume":"42","author":"Zhou","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jare.2012.05.002_b0600","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11745-997-0054-8","article-title":"A human dietary arachidonic acid supplementation study conducted in a metabolic research unit: rationale and design","volume":"32","author":"Nelson","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/j.jare.2012.05.002_b0605","doi-asserted-by":"crossref","unstructured":"Roberts MD, Iosia M, Kerksick CM, Taylor LW, Campbell B, Wilborn CD, et al. Effects of arachidonic acid supplementation on training adaptations in resistance-trained males. J Int Soc Sports Nutr 2007;28(4):21\u201334.","DOI":"10.1186\/1550-2783-4-21"},{"key":"10.1016\/j.jare.2012.05.002_b0610","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000059742","article-title":"Evolutionary aspects of diet and essential fatty acids","volume":"88","author":"Simopoulos","year":"2001","journal-title":"World Rev Nutr Diet"},{"key":"10.1016\/j.jare.2012.05.002_b0615","doi-asserted-by":"crossref","unstructured":"Simopoulos A. Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. Eur Heart J Suppl 2001;3(Suppl D):D8\u201321.","DOI":"10.1016\/S1520-765X(01)90113-0"},{"key":"10.1016\/j.jare.2012.05.002_b0620","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0278-6915(97)00025-2","article-title":"Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina: summary of toxicological data","volume":"35","author":"Hempenius","year":"1997","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jare.2012.05.002_b0625","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/AAC.00173-10","article-title":"In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium","volume":"4","author":"El Ridi","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2012.05.002_b0630","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijantimicag.2011.08.019","article-title":"Arachidonic acid efficacy and mechanism of action in treatment of hamsters infected with Schistosoma mansoni or S. haematobium","volume":"39","author":"El Ridi","year":"2012","journal-title":"Int J Antimicrobial Agents"},{"key":"10.1016\/j.jare.2012.05.002_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4894(83)90002-4","article-title":"A review. Schistosoma and related genera: Acquired resistance in mice","volume":"55","author":"Dean","year":"1983","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0640","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0035-9203(85)90391-8","article-title":"Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses","volume":"79","author":"Butterworth","year":"1985","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0645","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0035-9203(87)90359-2","article-title":"Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses","volume":"81","author":"Hagan","year":"1987","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0650","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.4049\/jimmunol.140.8.2727","article-title":"Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen","volume":"140","author":"Dessein","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0655","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0035-9203(89)90334-9","article-title":"The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil","volume":"83","author":"Correa-Oliveira","year":"1989","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0660","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/349243a0","article-title":"Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium","volume":"349","author":"Hagan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jare.2012.05.002_b0665","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0035-9203(94)90436-7","article-title":"Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni","volume":"88","author":"Viana","year":"1994","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0670","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1086\/515274","article-title":"T and B cell reactivity to a 42-kDa protein is associated with human resistance to both Schistosomiasis mansoni and haematobium","volume":"177","author":"El Ridi","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0675","doi-asserted-by":"crossref","unstructured":"El Ridi R, Shoemaker CB, Farouk F, El Sherif NH, Afifi A. Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy. Infect Immun 2001;69:237\u201344.","DOI":"10.1128\/IAI.69.1.237-244.2001"},{"key":"10.1016\/j.jare.2012.05.002_b0680","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.149.11.3612","article-title":"Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen","volume":"149","author":"Soisson","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0685","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.151.9.4782","article-title":"Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent","volume":"151","author":"Soisson","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0690","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/326149a0","article-title":"Molecular cloning of a protective antigen of schistosomes","volume":"326","author":"Balloul","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jare.2012.05.002_b0695","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-3024.1991.tb00545.x","article-title":"Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni","volume":"13","author":"Boulanger","year":"1991","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0700","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0166-6851(85)90075-1","article-title":"Identification by monoclonal antibodies of a major (28kDa) surface membrane antigen of Schistosoma mansoni","volume":"16","author":"Harn","year":"1985","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0705","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.148.2.562","article-title":"A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase","volume":"148","author":"Harn","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0710","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1073\/pnas.89.5.1842","article-title":"CDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase","volume":"89","author":"Shoemaker","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jare.2012.05.002_b0715","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.3094144","article-title":"Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice","volume":"234","author":"Lanar","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jare.2012.05.002_b0720","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2249.2005.02941.x","article-title":"Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection","volume":"142","author":"Fonseca","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0725","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1016\/S0021-9258(18)92995-9","article-title":"A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins","volume":"266","author":"Moser","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2012.05.002_b0730","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.135.3.2115","article-title":"Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites","volume":"135","author":"Harn","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0735","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.4049\/jimmunol.149.12.3995","article-title":"T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni","volume":"149","author":"Reynolds","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0740","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/expr.1993.1086","article-title":"Schistosoma mansoni: immuno-reactivity of human sera with the surface antigen Sm23","volume":"77","author":"Koster","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0745","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0166-6851(91)90078-K","article-title":"Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni","volume":"49","author":"Karcz","year":"1991","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0750","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.170.6.2065","article-title":"The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase","volume":"170","author":"Goudot-Crozel","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2012.05.002_b0755","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0166-6851(92)90184-L","article-title":"Complete sequence of the Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase gene encoding a major surface antigen","volume":"56","author":"Charrier-Ferrara","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0760","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/expr.1993.1032","article-title":"Schistosoma mansoni: identification and protective immunity of adult worm antigens recognized by T lymphocytes of outbred Swiss mice immunized with irradiated cercariae","volume":"76","author":"El Ridi","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0765","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2307\/3283413","article-title":"Identification of Schistosoma mansoni antigens recognized by T cells of C57BL\/6 mice immunized with gamma-irradiated cercariae","volume":"80","author":"Osman","year":"1994","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0770","doi-asserted-by":"crossref","unstructured":"Osman A, El Ridi R, Guirguis N, Dean DA. Identification of Schistosoma mansoni antigens recognized by spleen cells of C57B1\/6 mice immunized with ultraviolet-irradiated cercariae. Int J Parasitol 194;24:943\u201350.","DOI":"10.1016\/0020-7519(94)90158-9"},{"key":"10.1016\/j.jare.2012.05.002_b0775","unstructured":"Abdel Tawab N. Identification and molecular characterization of protective antigens against murine Schistosomiasis mansoni. Ph.D thesis. Faculty of Science, Cairo University; 1994. p. 280."},{"key":"10.1016\/j.jare.2012.05.002_b0780","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1645\/0022-3395(2000)086[0993:ASMKBI]2.0.CO;2","article-title":"A Schistosoma mansoni 62-kDa band is identified as an irradiated vaccine T-cell antigen and characterized as calreticulin","volume":"86","author":"El Gengehi","year":"2000","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0785","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0001-706X(03)00195-5","article-title":"In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens","volume":"88","author":"Al-Sherbiny","year":"2003","journal-title":"Acta Trop"},{"key":"10.1016\/j.jare.2012.05.002_b0790","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/IAI.68.5.2797-2803.2000","article-title":"Human immune responses to Schistosoma mansoni vaccine candidate antigens","volume":"68","author":"Ribeiro de Jesus","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jare.2012.05.002_b0795","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4269\/ajtmh.2002.66.348","article-title":"Practical and ethical issues in the development of a vaccine against Schistosomiasis mansoni","volume":"66","author":"Todd","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jare.2012.05.002_b0800","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.actatropica.2008.09.002","article-title":"The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine","volume":"108","author":"Tendler","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.jare.2012.05.002_b0805","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jare.2012.05.002_b0810","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0815","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-3083.2001.00992.x","article-title":"Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis","volume":"54","author":"El Ridi","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0820","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/S0264-410X(03)00180-4","article-title":"Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3- phosphate dehydrogenase","volume":"21","author":"Tallima","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jare.2012.05.002_b0825","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.0300-9475.2004.01497.x","article-title":"Immunogenicity and vaccine potential of di- peptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase","volume":"60","author":"El Ridi","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0830","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/psc.550","article-title":"Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL\/6 mice","volume":"10","author":"Veprek","year":"2004","journal-title":"J Pept Sci"},{"key":"10.1016\/j.jare.2012.05.002_b0835","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0169-4758(98)01319-2","article-title":"Glucose transport and metabolism in mammalian-stage schistosomes","volume":"14","author":"Skelly","year":"1998","journal-title":"Parasitol Today"},{"key":"10.1016\/j.jare.2012.05.002_b0840","unstructured":"Mahana NA. Human and murine immune responses to the Schistosoma mansoni glucose transporter. Ph.D thesis. Faculty of Science, Cairo University. p. 240."},{"key":"10.1016\/j.jare.2012.05.002_b0845","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"12","author":"Tran","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2012.05.002_b0850","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2008.05.042","article-title":"Molecular characterization of Schistosoma japonicum tegument protein tetraspanin-2: sequence variation and possible implications for immune evasion","volume":"372","author":"Cai","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2012.05.002_b0855","doi-asserted-by":"crossref","first-page":"e1166","DOI":"10.1371\/journal.pntd.0001166","article-title":"Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target","volume":"5","author":"Zhang","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0860","doi-asserted-by":"crossref","unstructured":"Cupit PM, Steinauer ML, Tonnessen BW, Eric Agola L, Kinuthia JM, Mwangi IN, et al. Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene. Int J Parasitol 2011; 41:1249\u201352.","DOI":"10.1016\/j.ijpara.2011.07.007"},{"key":"10.1016\/j.jare.2012.05.002_b0865","doi-asserted-by":"crossref","first-page":"e1564","DOI":"10.1371\/journal.pntd.0001564","article-title":"Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2","volume":"6","author":"Pearson","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2012.05.002_b0870","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jare.2012.05.002_b0875","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1645\/GE-864R.1","article-title":"No overt cellular inflammation around intravascular schistosomes in vivo","volume":"92","author":"Keating","year":"2006","journal-title":"J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0880","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijpara.2006.12.001","article-title":"Schistosome membrane proteins as vaccines","volume":"37","author":"Loukas","year":"2007","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0885","doi-asserted-by":"crossref","first-page":"180","DOI":"10.14411\/fp.2008.025","article-title":"Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase is a lung-stage schistosomula surface membrane antigen","volume":"55","author":"Tallima","year":"2008","journal-title":"Folia Parasitol (Praha)"},{"key":"10.1016\/j.jare.2012.05.002_b0890","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.vaccine.2008.11.039","article-title":"Schistosoma mansoni ex vivo lung-stage larvae excretory\u2013secretory antigens as vaccine candidates against schistosomiasis","volume":"27","author":"El Ridi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jare.2012.05.002_b0895","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0031182000079245","article-title":"Protein synthesis and release by cultured schistosomula of Schistosoma mansoni","volume":"107","author":"Harrop","year":"1993","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0900","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S003118209900431X","article-title":"Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni","volume":"118","author":"Harrop","year":"1999","journal-title":"Parasitology"},{"key":"10.1016\/j.jare.2012.05.002_b0905","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2004.06.016","article-title":"The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages","volume":"138","author":"Curwen","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0910","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1074\/mcp.M500097-MCP200","article-title":"Proteomic analysis of Schistosoma mansoni cercarial secretions","volume":"4","author":"Knudsen","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jare.2012.05.002_b0915","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1074\/mcp.M500313-MCP200","article-title":"Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry","volume":"5","author":"Curwen","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jare.2012.05.002_b0920","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.coi.2004.03.002","article-title":"Emerging paradigms of T-cell co-stimulation","volume":"16","author":"Kroczek","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0925","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.173.1.159","article-title":"Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni","volume":"173","author":"Pearce","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2012.05.002_b0930","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0065-308X(08)60048-2","article-title":"The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?","volume":"39","author":"Coulson","year":"1997","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b0935","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-3083.2008.02131.x","article-title":"Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger na\u00efve donor immune response towards a type-1 cytokine profile","volume":"68","author":"Reis","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0940","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.micinf.2010.04.012","article-title":"Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory\u2013secretory candidate vaccine antigens","volume":"12","author":"El Ridi","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jare.2012.05.002_b0945","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2007-12-077917","article-title":"The phagocytes: neutrophils and monocytes","volume":"112","author":"Dale","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jare.2012.05.002_b0950","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri2532","article-title":"Intravascular immunity: the host-pathogen encounter in blood vessels","volume":"9","author":"Hickey","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0955","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.153.11.5200","article-title":"Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni","volume":"153","author":"Wynn","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0960","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/iai.65.1.219-226.1997","article-title":"Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni","volume":"65","author":"Ahmed","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jare.2012.05.002_b0965","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2009.07.581","article-title":"Transforming growth factor-\u03b2 and Th17 responses in innate resistance to murine Schistosomiasis mansoni","volume":"48","author":"Tallima","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.jare.2012.05.002_b0970","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1096\/fj.01-0690hyp","article-title":"Regional manifestations and control of the immune system","volume":"16","author":"Saadi","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2012.05.002_b0975","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","article-title":"IL-33, a potent inducer of adaptive immunity to intestinal nematodes","volume":"180","author":"Humphreys","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0980","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","article-title":"Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites","volume":"226","author":"Saenz","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jare.2012.05.002_b0985","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ni.1883","article-title":"The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling","volume":"11","author":"Tang","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2012.05.002_b0990","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature10329","article-title":"TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation","volume":"477","author":"Siracusa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jare.2012.05.002_b0995","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pt.2011.01.001","article-title":"Nuocytes and beyond: new insights into helminth expulsion","volume":"27","author":"Neill","year":"2011","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jare.2012.05.002_b1000","doi-asserted-by":"crossref","unstructured":"El Ridi R, Tallima H. Vaccine-induced protection against murine Schistosomiasis mansoni with larval excretory\u2013secretory antigens and papain or type-2 cytokines. J Parasitol 2013;99:194\u2013202.","DOI":"10.1645\/GE-3186.1"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123212000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123212000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:39:45Z","timestamp":1761856785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123212000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":200,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2090123212000318"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2012.05.002","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Therapeutic and Prevention Approaches for Schistosomiasis: Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2012.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}